Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-9-22
pubmed:abstractText
Some growth hormone secretagogues act as agonists at the ghrelin receptor and have been described as "ago-allosteric" ligands because of an ability to also modulate the maximum efficacy and potency of ghrelin (Holst et al., 2005). In membranes prepared from cells coexpressing the human ghrelin receptor and the G protein Galpha(o1), N-[1(R)-1, 2-dihydro-1-ethanesulfonylspiro-3H-indole-3,4'-piperidin)-1'-yl]carbonyl-2-(phenylmethoxy)-ethyl-2-amino-2-methylpropanamide (MK-677), growth hormone-releasing peptide 6 (GHRP-6), and the 2(R)-hydroxypropyl derivative of 3-amino-3-methyl-N-(2,3,4,5-tetrahydro-2-oxo-1-([2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl]methyl)-1H-1-benzazepin-3(R)-yl)-butanamide (L-692,585) each functioned as direct agonists, and each displayed higher efficacy than ghrelin. The effect of multiple, fixed concentrations of each of these ligands on the function and concentration-dependence of ghrelin and the effect of multiple, fixed concentrations of ghrelin on the action of MK-677, GHRP-6, and L-692,585 was analyzed globally according to a modified version of an operational model of allosterism that accounts for allosteric modulation of affinity, efficacy, and allosteric agonism. Each of the data sets was best fit by a model of simple competition between a partial and a full agonist. Both positive and negative allosteric modulators are anticipated to alter the kinetics of binding of an orthosteric agonist. However, none of the proposed ago-allosteric regulators tested had any effect on the dissociation kinetics of (125)I-[His]-ghrelin, and GHRP-6 and MK-677 were able to fully displace (125)I-[His]-ghrelin from the receptor. At least in the system tested, each of the ligands acted in a simple competitive fashion with ghrelin as demonstrated by analysis according to a model whereby ghrelin is a partial agonist with respect to each of the synthetic agonists tested.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-11314756, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-12907757, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-12960033, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-14645655, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-15180951, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-15509716, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-15777186, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-15788704, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-15905359, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-16511600, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-16511605, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-16595341, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-16798937, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-16803859, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-16889837, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17015451, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17069751, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17139258, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17395087, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17452637, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17525997, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17561373, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17575083, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17629965, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17717108, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-17965750, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-18022255, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-18033822, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-18307412, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-18923064, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-19116626, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-2828914, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-6141562, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-7482982, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-8688086, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-8725397, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-9032459, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-9440817, http://linkedlifedata.com/resource/pubmed/commentcorrection/19625579-9590567
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1521-0111
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
802-11
pubmed:dateRevised
2010-9-24
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor.
pubmed:affiliation
Molecular Pharmacology Group, Neuroscience and Molecular Pharmacology, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't